Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Comment by LakeOromoctoon Sep 21, 2016 5:36pm
250 Views
Post# 25262816

RE:questions for agm

RE:questions for agm just home from the meeting!

answers to your questions:
1. no answer on when negotiations will start, they (wanbang) are proceeding but very slowly I gathered from my conversation with them.

2. They have finished their portion of the research on Keloid and now it requires an investment of approx 110,000 euros to complete, so its on hold at this time.

3. 1067 could be ready within one year as a prescription medicine, and 2 years as a cosmetic.

they will be releasing a new video on youtube that was produced in Germany, we watched it today and it was very well done.  basically the same info but laid out in a more detailed manor.... you will like.

the mood was very upbeat and they are excited about a deal for 1067, I left the meeting very positive a deal will happen!

any other questions pls let me know.
Bullboard Posts